Advertisement
Screener

Inspire Medical Systems, Inc. (INSP) Payments to Acquire Other Investments

3.3 / 5 stars · 54/81 Roast Me

Inspire Medical Systems, Inc. Payments to Acquire Other Investments

Inspire Medical Systems, Inc. (INSP) reported Payments to Acquire Other Investments of $10.12 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireOtherInvestments · last filed 2026-02-13

  • Inspire Medical Systems, Inc. payments to acquire other investments for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
  • Inspire Medical Systems, Inc. payments to acquire other investments for the quarter ending 2025-09-30 was $7.60M.
  • Inspire Medical Systems, Inc. payments to acquire other investments for the quarter ending 2025-06-30 was $1.92M.
  • Inspire Medical Systems, Inc. payments to acquire other investments for the quarter ending 2025-03-31 was $600.00K.
  • Inspire Medical Systems, Inc. payments to acquire other investments for fiscal 2025 was $10.12M, a 3947.20% increase from fiscal 2024.
  • Inspire Medical Systems, Inc. payments to acquire other investments for fiscal 2024 was $250.00K, a 0.00% change from fiscal 2023.
  • Inspire Medical Systems, Inc. payments to acquire other investments for fiscal 2023 was $250.00K, a 97.62% decline from fiscal 2022.
  • Inspire Medical Systems, Inc. payments to acquire other investments for fiscal 2022 was $10.50M.
Period endPayments to Acquire Other Investments 3 monthPayments to Acquire Other Investments 6 monthPayments to Acquire Other Investments 9 monthPayments to Acquire Other Investments 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$7.60M
derived: sum of 2 quarters · filed 2026-02-13
$9.52M
derived: sum of 3 quarters · filed 2026-02-13
$10.12M
10-K · filed 2026-02-13
2025-09-30$7.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$9.52M
derived: sum of 2 quarters · filed 2025-11-03
$10.12M
10-Q · filed 2025-11-03
$10.37M
derived: sum of 4 quarters · filed 2026-02-13
2025-06-30$1.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$2.52M
10-Q · filed 2025-08-04
$2.77M
derived: sum of 3 quarters · filed 2026-02-13
$2.77M
derived: sum of 4 quarters · filed 2026-02-13
2025-03-31$600.00K
10-Q · filed 2025-05-05
$850.00K
derived: sum of 2 quarters · filed 2026-02-13
$850.00K
derived: sum of 3 quarters · filed 2026-02-13
$850.00K
derived: sum of 4 quarters · filed 2026-02-13
2024-12-31$250.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$250.00K
derived: sum of 2 quarters · filed 2026-02-13
$250.00K
derived: sum of 3 quarters · filed 2026-02-13
$250.00K
10-K · filed 2026-02-13
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03
$0.00
derived: sum of 2 quarters · filed 2025-11-03
$0.00
10-Q · filed 2025-11-03
$0.00
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$0.00
10-Q · filed 2025-08-04
$0.00
derived: sum of 3 quarters · filed 2026-02-13
$0.00
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31$0.00
10-Q · filed 2025-05-05
$0.00
derived: sum of 2 quarters · filed 2026-02-13
$0.00
derived: sum of 3 quarters · filed 2026-02-13
$250.00K
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$0.00
derived: sum of 2 quarters · filed 2026-02-13
$250.00K
derived: sum of 3 quarters · filed 2026-02-13
$250.00K
10-K · filed 2026-02-13
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$250.00K
derived: sum of 2 quarters · filed 2024-11-04
$250.00K
10-Q · filed 2024-11-04
$250.00K
derived: sum of 4 quarters · filed 2025-02-10
2023-06-30$250.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$250.00K
10-Q · filed 2024-08-06
$250.00K
derived: sum of 3 quarters · filed 2025-02-10
$500.00K
derived: sum of 4 quarters · filed 2025-02-10
2023-03-31$0.00
10-Q · filed 2023-05-02
$0.00
derived: sum of 2 quarters · filed 2025-02-10
$250.00K
derived: sum of 3 quarters · filed 2025-02-10
$10.25M
derived: sum of 4 quarters · filed 2025-02-10
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10
$250.00K
derived: sum of 2 quarters · filed 2025-02-10
$10.25M
derived: sum of 3 quarters · filed 2025-02-10
$10.50M
10-K · filed 2025-02-10
2022-09-30$250.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$10.25M
derived: sum of 2 quarters · filed 2023-11-07
$10.50M
10-Q · filed 2023-11-07
$10.50M
derived: sum of 4 quarters · filed 2024-02-09
2022-06-30$10.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$10.25M
10-Q · filed 2023-08-01
$10.25M
derived: sum of 3 quarters · filed 2024-02-09
$10.25M
derived: sum of 4 quarters · filed 2024-02-09
2022-03-31$250.00K
10-Q · filed 2023-05-02
$250.00K
derived: sum of 2 quarters · filed 2024-02-09
$250.00K
derived: sum of 3 quarters · filed 2024-02-09
$250.00K
derived: sum of 4 quarters · filed 2024-02-09
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09
$0.00
derived: sum of 2 quarters · filed 2024-02-09
$0.00
derived: sum of 3 quarters · filed 2024-02-09
$0.00
10-K · filed 2024-02-09
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$0.00
derived: sum of 2 quarters · filed 2022-11-01
$0.00
10-Q · filed 2022-11-01
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$0.00
10-Q · filed 2022-08-02
2021-03-31$0.00
10-Q · filed 2022-05-03
2020-12-31$0.00
10-K · filed 2023-02-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77